期刊文献+

ACS患者体内同型半胱氨酸与黏附分子CD11b/CD18的相关性 被引量:1

The correlation between homocysteine level and CD11b/CD18 expression on leucocytes in the patients with acute coronary syndrome
暂未订购
导出
摘要 目的:探讨急性冠脉综合征患者体内血浆同型半胱氨酸(HCY)与全血白细胞黏附分子CD11b/CD18水平的变化及其相关性。方法:对急性冠脉综合征(ACS)患者53例与健康人35例采用酶联免疫法测定血浆HCY水平,通过流式细胞仪采用直接免疫荧光法测定白细胞黏附分子CD11b/CD18的表达。结果:ACS组血浆HCY水平显著高于对照组,分别为29.1±13.5和12.7±6.9μmol/L(P<0.01),ACS组白细胞表面CD11b/CD18表达水平显著高于对照组,分别为6.0±2.3比4.3±1.6 MFI(P<0.05),27.7±7.7比19.6±4.9 MFI(P<0.05)。HCY水平与CD11b、CD18的表达显著相关。结论:同型半胱氨酸作为炎症介质可能通过调节白细胞黏附分子CD11b/CD18的表达,在ACS发生和发展中起重要作用。 AIM: To evaluate the plasma homocysteine level and CD11b/CD18 expression on leukocytes in whole blood and their relationship in patients with acute coronary syndrome (ACS ). METHODS: Our study included 53 patients with ACS and 35 healthy controls based on their clinical situation, electrocardiogram, cardiac enzyme, cTNT and etc. HCY level was measured by enzyme immunoassay and leukocyte surface adhesive molecule CD11b/CD18 expressions were analyzed by immunofluorescence flow cytometry. RESULTS: The levels of plasma homocysteine were markedly increased and the expressions of CD11b/CD18 on leucocytes were significantly increased in patients with ACS compared to control group. The correlation between homocysteine level and CD11b/CD18 expression was positive in ACS. CONCLUSION: Homocysteine might play an important role in the occurrence of ACS by mediating expression of CD11b/CD18 on leukocyte as an inflammatory medium.
出处 《心脏杂志》 CAS 2005年第4期365-366,共2页 Chinese Heart Journal
关键词 急性冠脉综合征 同型半胱氨酸 白细胞黏附分子 acute coronary syndrome homocysteine CD11b/CD18
  • 相关文献

参考文献8

  • 1金雪娟,潘信伟,傅华.高同型半胱氨酸血症-冠心病、脑卒中的又一独立危险因素[J].上海预防医学,2000,12(1):37-39. 被引量:11
  • 2Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease, a possible role for methionine metabolism [ J ]. Journal of Clinical Investigation, 1976,57 : 1079 - 1082.
  • 3Nikfardjam M, Graf S, Homykewycz S, et al. Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease[J]. Thromb Res, 2001,103 (Suppl 1) :S35-S39.
  • 4Snehalatha C, Ramachandran A, Satyavani K, et al. Plasma homocysteine concentration and coronary artery disease in asian indians[J]. Assoc Physicians India, 2002 ,50:1229 -1231.
  • 5郭雪微,Dudman Nicholas Peter.Homocysteine alters monocyte-endothelial interaction in vitro[J].Chinese Medical Journal,2003(1):34-38. 被引量:17
  • 6Nicholas PB. Dudman NP, Suzanna ET, et al. Homocysteine enhances neutropil-endothelial interactions in both cultered human cells and rats in vivo[ J]. Circu res,1999 ,84(4) :409 -416.
  • 7郭雪微,Dudman NP.同型半胱氨酸增强血白细胞粘附分子的表达[J].基础医学与临床,2001,21(2):144-147. 被引量:6
  • 8Pancharuniti N, Lewis CA, Sauberlich HE, et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for earlyonset coronary artery disease[J] . Am J Clin Nutr, 1996,63(4) :609.

二级参考文献18

  • 1Dudman N P,Circulation Research,1999年,4卷,409页
  • 2Jang Y,J Am Coll Cardiol,1994年,24卷,1591页
  • 3Genest JJ, Mcnarnara JR, Salem DN, et al. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardio, 1990,16:1114-1119.
  • 4Coull BM, Malinow MR, Beamer N, et al.Evaluated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke, 1990, 21:572.
  • 5Stampfer MJ, Malinow MR, Willett WC,et al. A prospective study of plasma homocysteine and risk of myocardial infarction in U S physicians. JAMA, 1992,268: 877-881.
  • 6Arnesen E, Relsum H, Bonaa KH, et al,Serum total homocysteine and coronary heart disease. Int. J Epidemiol, 1995, 24:704-709.
  • 7Boushey CJ, Beresford AA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascullar disease; probable benefits of inereasing folic acid intake. JAMA, 1995, 274:1049 - 1057.
  • 8Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemla: an independent risk factor for vascuar disease. N Engl J Med, 1991,324: 1149-1155.
  • 9Graham Lam M, Daly Leslie E, Refsum Helga M, et al. Plasma homoeysteine as a risk factor for vascular disease. JAMA, 1997,277: 1775 - 1781.
  • 10Refsum H, Ueland P. M. Nygard O, et al. Homocysteine and Cardiovascular Disease.Annu. Rev. Medicine, 1998, 49:31-62.

共引文献30

同被引文献9

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部